Skip to main content
Expert Interview

Ask the Expert: S. Kaye Spratt, PhD

Discussing Advanced therapies, early regulatory interactions and her experience at RareMoon

November 17, 2025
5 min read
S. Kaye Spratt, PhD
Ask the Expert: S. Kaye Spratt, PhD - RareMoon's Senior Regulatory Consultant & Scientific Advisor
Share this article:
Back to all insights →

Related Insights

Expert InterviewJune 5, 2025

Ask the Expert: Lilia Bi, MD, PhD

We sat down with Dr. Lilia Bi to discuss her extensive regulatory experience and insights for gene therapy developers.

Read more →
Expert InterviewJanuary 3, 2025

Ask the Expert: Mette Due Theilade Thomsen, Ph.D.

Sponsors often struggle with early PIP submissions for pediatric gene therapies due to their complexity.

Read more →
Gene TherapyJune 2, 2025

Hope on the Horizon: Breakthrough for MPS IIIA

The second half of 2025 is shaping up to be a pivotal period for advanced therapies.

Read more →

Stay Informed

Get the latest regulatory insights and expert perspectives delivered to your inbox.